Favorable mortality-to-incidence ratios of kidney Cancer are associated with advanced health care systems

BMC Cancer

Table 1 Summary of the number of cases, rates, and mortality-to-incidence ratios of kidney cancer according to region

Region	Number		Crude rate		Age-standardized rate		Mortality-to-incidence ratio^a
Region	Incidence	Mortality	Incidence	Mortality	Incidence	Mortality	Mortality-to-incidence ratio^a
World	337,860	143,406	4.8	2.0	4.4	1.8	0.42
Development
More developed regions	199,991	74,948	16.1	6.0	9.2	2.8	0.37
Less developed regions	137,869	68,458	2.4	1.2	2.6	1.3	0.50
WHO region categories
WHO Africa region	6725	5649	0.8	0.6	1.0	0.8	0.75
WHO Americas region	85,005	27,949	8.9	2.9	7.3	2.2	0.33
WHO East Mediterranean region	8952	6628	1.4	1.1	1.9	1.5	0.79
WHO Europe region	121,629	52,816	13.5	5.9	8.3	3.1	0.44
WHO South-East Asia region	17,050	11,399	0.9	0.6	1.1	0.7	0.67
WHO Western Pacific region	98,473	38,951	5.3	2.1	4.1	1.5	0.40
Continent
Africa	10,033	8169	0.9	0.8	1.2	1.0	0.89
Latin America and Caribbean	21,183	11,308	3.5	1.9	3.5	1.8	0.54
Northern America	63,822	16,641	18.2	4.7	11.7	2.6	0.26
Asia	123,402	57,058	2.9	1.3	2.8	1.3	0.45
Europe	115,252	49,025	15.5	6.6	8.8	3.1	0.43
Oceania	4168	1205	11.0	3.2	8.0	2.0	0.29

^athe percentage in the ratio of the crude rate of mortalities and the crude rate of incidences

ISSN: 1471-2407